ClinicalTrials.Veeva

Menu

An Exploratory Investigation of Dietary Supplementation and Its Effect

H

HUM Nutrition

Status

Completed

Conditions

Quality of Life

Treatments

Dietary Supplement: Placebo
Dietary Supplement: HUM supplement

Study type

Interventional

Funder types

Industry

Identifiers

NCT05037877
20220HUM

Details and patient eligibility

About

The primary objective of this study is to understand if the test product (HUM supplement) improve symptoms experienced.

Full description

This will be a 2-arm randomized, double-blinded, placebo-controlled study.

Enrollment

110 patients

Sex

Female

Ages

38 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Female
  • Willing to maintain the current dietary pattern, activity level, and stable body weight for the duration of the study
  • Must be in good health (don't report any medical conditions asked in the screening questionnaire)
  • Willing and able to provide written informed consent

Exclusion criteria

  • Allergies to any test product ingredients
  • Any other severe chronic disease
  • Pregnant, want to become pregnant for the duration of the study, or who are breastfeeding
  • Participating in an investigational health product research study

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

110 participants in 2 patient groups, including a placebo group

Intervention group
Active Comparator group
Description:
HUM supplement - 1 capsule per day
Treatment:
Dietary Supplement: HUM supplement
Placebo group
Placebo Comparator group
Description:
Placebo supplement - 1 capsule per day
Treatment:
Dietary Supplement: Placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems